Directory

>

Fred D'amato

avatar

Fred D'amato

Executive Director | Kura Oncology, Inc.

Boston, Massachusetts, United States

View contact details (it's free)

Fred D'amato

Summary

Fred D'amato is an accomplished Executive Director at Kura Oncology, Inc., with over 15 years of extensive experience in clinical program management and operations. He holds a Master of Science in Pharmacology and has a proven track record in leading multi-national studies involving small molecules and biologics, particularly in orphan indications. His expertise spans several therapeutic areas, including oncology, neurology, and hemophilia. Fred has a keen interest in novel study designs and emerging markets, showcasing his innovative approach to clinical research. He has held various leadership roles, demonstrating a strong ability to manage cross-functional teams effectively. His career reflects a commitment to advancing clinical trials and improving patient outcomes through rigorous research methodologies.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Fred D'amato

Work Experience

company logo

Executive Director at

Kura Oncology, Inc.

December 2023 - Present

company logo

Sr. Director - Clinical Operations Lead at

Kura Oncology, Inc.

June 2022 - December 2023

company logo

Director - Clinical Operations Lead at

Kura Oncology, Inc.

September 2020 - June 2022

company logo

Director - Gene Therapy, Clinical Operations at

Sarepta Therapeutics

February 2019 - September 2020

company logo

Associate Director Clinical Operations at

Sarepta Therapeutics

April 2018 - February 2019

company logo

Associate Director, Clinical Program Support at

Shire

June 2016 - November 2017

company logo

Clinical Program Lead, Clinical Operations at

Baxalta

March 2015 - October 2016

company logo

Senior Clinical Study Manager at

Takeda Pharmaceuticals America, Inc.

May 2014 - February 2015

company logo

Senior Clinical Trial Manager at

Biogen

February 2013 - May 2014

company logo

Clinical Trial Manager at

Biogen

February 2009 - February 2013

company logo

Sr. Clinical Trial Coordinator/Acting Clinical Trial Manager at

Biogen

September 2007 - February 2009

💼

Clinical Research Associate II at

Dana Farberharvard Cancer Center At Mgh

January 2005 - January 2007

Logos provided by Logo.dev

Fred D'amato

Education

Northeastern University, Ms

January 2005 - January 2007

Saint Anselm College, Ba

January 1993 - January 1997

Frequently Asked Questions about Fred D'amato

What is Fred D'amato email address?

Fred D'amato's primary email address is *******@sarepta.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Fred D'amato work for?

Fred D'amato is a Executive Director at Kura Oncology, Inc., a company specializing in Commercial physical research.

Where Fred D'amato graduated from?

Fred D'amato holds a degree in Pharmacology from Northeastern University.

How can I directly contact Fred D'amato?

To contact Fred D'amato directly, you can use the email address *******@sarepta.com. Complete contact information is available upon registration with Muraena.

Who is Fred D'amato?

Fred D'amato is an accomplished Executive Director at Kura Oncology, Inc., with over 15 years of extensive experience in clinical program management and operations. He holds a Master of Science in Pharmacology and has a proven track record in leading multi-national studies involving small molecules and biologics, particularly in orphan indications. His expertise spans several therapeutic areas, including oncology, neurology, and hemophilia. Fred has a keen interest in novel study designs and emerging markets, showcasing his innovative approach to clinical research. He has held various leadership roles, demonstrating a strong ability to manage cross-functional teams effectively. His career reflects a commitment to advancing clinical trials and improving patient outcomes through rigorous research methodologies.

Fred`s contact details

mail

*******@sarepta.com

***********@takeda.com

*******@kuraoncology.com

Colleagues

Paul Inglese

Executive Director Clinical Data Sciences

avatar
Pete De Spain

Executive Vice President, Investor Relations & Corporate Communications

avatar
Teresa Brophy Bair

Chief Legal Officer

avatar
Thomas Doyle

Senior Vice President, Finance and Accounting & Principal Accounting Officer

avatar
Mollie Leoni Md

Executive Vice President Clinical Development

Stephen Dale Md

Chief Medical Officer and Head of R&D

avatar
Ryan Snyder

Vice President Business Development

avatar
Kathy Ford

Chief Operating Officer

avatar
Kelly Cannan-Kennerly Sphr

Vice President, Human Resources

avatar
Donna Edgerton

Vice President Quality Assurance

View Contact details (it's free)
Request Profile Removal